Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening

Sung Soo Ahn, Seung Min Jung, Juyoung Yoo, Sang Won Lee, Jason Jungsik Song, Yong Beom Park

Research output: Contribution to journalArticle

Abstract

A false-positive result of syphilis screening test (FPST) is a characteristic finding in patients with systemic lupus erythematosus (SLE). We evaluated the clinical characteristics of SLE patients with FPST at SLE diagnosis. We reviewed the medical records of patients with SLE who underwent the Venereal Disease Research Laboratory or Rapid Plasma Reagin tests at SLE diagnosis at Severance Hospital between 2006 and 2016. The baseline characteristics and clinical outcomes were compared between patients with FPST and those with a negative result of syphilis screening test. Of 145 patients with SLE, 20 patients showed FPST and 125 patients showed a negative syphilis screening result. At SLE diagnosis, patients with a negative result had higher SLE disease activity index (5.0 vs. 8.0, P < 0.001) and were more commonly complicated with nephritis (15.0% vs. 41.6%, P = 0.026). High level of serum total protein (> 8 g/dL) and the presence of anti-cardiolipin antibodies were independently associated with FPST (P = 0.010 and 0.037, respectively). During the follow-up (median 61 months), 5 patients with FPST (20.0%) and 12 patients without FPST (9.6%) were finally diagnosed with APS. The long-term risk of de novo thrombosis was higher in the FPST group (n = 4/20, 20% vs n = 6/125, 4.8%, P = 0.041). However, all-cause mortality showed no difference between the FPST group and the negative group. Patients with SLE showing FPST showed lower disease activity at SLE diagnosis but higher thrombotic risk and similar overall survival compared to those without FPST.

Original languageEnglish
Pages (from-to)1859-1866
Number of pages8
JournalRheumatology International
Volume39
Issue number11
DOIs
Publication statusPublished - 2019 Nov 1

Fingerprint

Syphilis
Systemic Lupus Erythematosus
Reagins
Cardiolipins
Sexually Transmitted Diseases
Medical Records
Anti-Idiotypic Antibodies
Thrombosis

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Ahn, Sung Soo ; Jung, Seung Min ; Yoo, Juyoung ; Lee, Sang Won ; Song, Jason Jungsik ; Park, Yong Beom. / Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening. In: Rheumatology International. 2019 ; Vol. 39, No. 11. pp. 1859-1866.
@article{e7550bb890d748498493ce0127d72083,
title = "Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening",
abstract = "A false-positive result of syphilis screening test (FPST) is a characteristic finding in patients with systemic lupus erythematosus (SLE). We evaluated the clinical characteristics of SLE patients with FPST at SLE diagnosis. We reviewed the medical records of patients with SLE who underwent the Venereal Disease Research Laboratory or Rapid Plasma Reagin tests at SLE diagnosis at Severance Hospital between 2006 and 2016. The baseline characteristics and clinical outcomes were compared between patients with FPST and those with a negative result of syphilis screening test. Of 145 patients with SLE, 20 patients showed FPST and 125 patients showed a negative syphilis screening result. At SLE diagnosis, patients with a negative result had higher SLE disease activity index (5.0 vs. 8.0, P < 0.001) and were more commonly complicated with nephritis (15.0{\%} vs. 41.6{\%}, P = 0.026). High level of serum total protein (> 8 g/dL) and the presence of anti-cardiolipin antibodies were independently associated with FPST (P = 0.010 and 0.037, respectively). During the follow-up (median 61 months), 5 patients with FPST (20.0{\%}) and 12 patients without FPST (9.6{\%}) were finally diagnosed with APS. The long-term risk of de novo thrombosis was higher in the FPST group (n = 4/20, 20{\%} vs n = 6/125, 4.8{\%}, P = 0.041). However, all-cause mortality showed no difference between the FPST group and the negative group. Patients with SLE showing FPST showed lower disease activity at SLE diagnosis but higher thrombotic risk and similar overall survival compared to those without FPST.",
author = "Ahn, {Sung Soo} and Jung, {Seung Min} and Juyoung Yoo and Lee, {Sang Won} and Song, {Jason Jungsik} and Park, {Yong Beom}",
year = "2019",
month = "11",
day = "1",
doi = "10.1007/s00296-019-04435-0",
language = "English",
volume = "39",
pages = "1859--1866",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "11",

}

Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening. / Ahn, Sung Soo; Jung, Seung Min; Yoo, Juyoung; Lee, Sang Won; Song, Jason Jungsik; Park, Yong Beom.

In: Rheumatology International, Vol. 39, No. 11, 01.11.2019, p. 1859-1866.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening

AU - Ahn, Sung Soo

AU - Jung, Seung Min

AU - Yoo, Juyoung

AU - Lee, Sang Won

AU - Song, Jason Jungsik

AU - Park, Yong Beom

PY - 2019/11/1

Y1 - 2019/11/1

N2 - A false-positive result of syphilis screening test (FPST) is a characteristic finding in patients with systemic lupus erythematosus (SLE). We evaluated the clinical characteristics of SLE patients with FPST at SLE diagnosis. We reviewed the medical records of patients with SLE who underwent the Venereal Disease Research Laboratory or Rapid Plasma Reagin tests at SLE diagnosis at Severance Hospital between 2006 and 2016. The baseline characteristics and clinical outcomes were compared between patients with FPST and those with a negative result of syphilis screening test. Of 145 patients with SLE, 20 patients showed FPST and 125 patients showed a negative syphilis screening result. At SLE diagnosis, patients with a negative result had higher SLE disease activity index (5.0 vs. 8.0, P < 0.001) and were more commonly complicated with nephritis (15.0% vs. 41.6%, P = 0.026). High level of serum total protein (> 8 g/dL) and the presence of anti-cardiolipin antibodies were independently associated with FPST (P = 0.010 and 0.037, respectively). During the follow-up (median 61 months), 5 patients with FPST (20.0%) and 12 patients without FPST (9.6%) were finally diagnosed with APS. The long-term risk of de novo thrombosis was higher in the FPST group (n = 4/20, 20% vs n = 6/125, 4.8%, P = 0.041). However, all-cause mortality showed no difference between the FPST group and the negative group. Patients with SLE showing FPST showed lower disease activity at SLE diagnosis but higher thrombotic risk and similar overall survival compared to those without FPST.

AB - A false-positive result of syphilis screening test (FPST) is a characteristic finding in patients with systemic lupus erythematosus (SLE). We evaluated the clinical characteristics of SLE patients with FPST at SLE diagnosis. We reviewed the medical records of patients with SLE who underwent the Venereal Disease Research Laboratory or Rapid Plasma Reagin tests at SLE diagnosis at Severance Hospital between 2006 and 2016. The baseline characteristics and clinical outcomes were compared between patients with FPST and those with a negative result of syphilis screening test. Of 145 patients with SLE, 20 patients showed FPST and 125 patients showed a negative syphilis screening result. At SLE diagnosis, patients with a negative result had higher SLE disease activity index (5.0 vs. 8.0, P < 0.001) and were more commonly complicated with nephritis (15.0% vs. 41.6%, P = 0.026). High level of serum total protein (> 8 g/dL) and the presence of anti-cardiolipin antibodies were independently associated with FPST (P = 0.010 and 0.037, respectively). During the follow-up (median 61 months), 5 patients with FPST (20.0%) and 12 patients without FPST (9.6%) were finally diagnosed with APS. The long-term risk of de novo thrombosis was higher in the FPST group (n = 4/20, 20% vs n = 6/125, 4.8%, P = 0.041). However, all-cause mortality showed no difference between the FPST group and the negative group. Patients with SLE showing FPST showed lower disease activity at SLE diagnosis but higher thrombotic risk and similar overall survival compared to those without FPST.

UR - http://www.scopus.com/inward/record.url?scp=85071630629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071630629&partnerID=8YFLogxK

U2 - 10.1007/s00296-019-04435-0

DO - 10.1007/s00296-019-04435-0

M3 - Article

C2 - 31468123

AN - SCOPUS:85071630629

VL - 39

SP - 1859

EP - 1866

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 11

ER -